Federation des caisses Desjardins du Quebec’s Enanta Pharmaceuticals ENTA Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio ENTA Stock Details ENTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-866	Closed	-$45.1K	–	2155
2020 Q1	$45.1K	Sell	866 -5,192	-86%	-$277K	﹤0.01%	1283
2019 Q4	$374K	Hold	6,058	–	–	0.01%	854
2019 Q3	$364K	Hold	6,058	–	–	0.01%	852
2019 Q2	$510K	Hold	6,058	–	–	0.01%	777
2019 Q1	$579K	Hold	6,058	–	–	0.01%	708
2018 Q4	$430K	Hold	6,058	–	–	0.01%	753
2018 Q3	$518K	Hold	6,058	–	–	0.01%	743
2018 Q2	$703K	Hold	6,058	–	–	0.01%	699
2018 Q1	$490K	Buy	+6,058	New	+$466K	0.01%	748
2017 Q4	–	Sell	-1,000	Closed	-$46.8K	–	2144
2017 Q3	$46.8K	Hold	1,000	–	–	﹤0.01%	1331
2017 Q2	$36K	Sell	1,000 -858	-46%	-$27.4K	﹤0.01%	1440
2017 Q1	$57.2K	Buy	+1,858	New	+$57.9K	﹤0.01%	1121

Other funds holding ENTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's ENTA Position: Q2 2020 in Review

Federation des caisses Desjardins du Quebec sold out of Enanta Pharmaceuticals (ENTA) in Q2 2020, closing a stake of 866 shares — an estimated $45.1K sold.

Federation des caisses Desjardins du Quebec first reported a position in ENTA in Q1 2017 and held it in 12 quarters. The position peaked at $703K in Q2 2018. 180 funds tracked by Wall St. Rank hold ENTA as of Q2 2020.

Federation des caisses Desjardins du Quebec reported no remaining Enanta Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 866 Enanta Pharmaceuticals shares in Q2 2020, an estimated $45.1K.
Federation des caisses Desjardins du Quebec first reported a position in Enanta Pharmaceuticals in Q1 2017 and held it in 12 quarters.
Federation des caisses Desjardins du Quebec's Enanta Pharmaceuticals position peaked at $703K in Q2 2018.
180 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2020.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2020, filed 30 Aug 2024.